Structural validity of the Brazilian version of the quality care questionnaire-palliative care for use in individuals with diabetes mellitus eligible for palliative care
2024

Validating a Questionnaire for Palliative Care in Diabetic Patients

Sample size: 100 publication Evidence: high

Author Information

Author(s): Mendes-Júnior Abraão Albino, Santos-de-Araújo Aldair Darlan, de Oliveira Silva Santos Leonel Richard, Ladeira Lorena Lúcia Costa, Ferreira Meire Coelho, Godim Louise Aline Romão, Maia Mariana Campos, de Farias Diniz Marinete Rodrigues, Dibai-Filho Almir Vieira, Bassi-Dibai Daniela

Primary Institution: Ceuma University

Hypothesis

The Brazilian version of the Quality Care Questionnaire-Palliative Care (QCQ-PC) can be structurally validated for individuals with diabetes mellitus eligible for palliative care.

Conclusion

The internal structure with one domain (quality of care) is the most suitable for use in individuals with diabetes mellitus eligible for palliative care by means of the QCQ-PC.

Supporting Evidence

  • The QCQ-PC was previously validated for cancer patients but needed validation for other populations.
  • Exploratory factor analysis identified a single domain for the QCQ-PC in diabetic patients.
  • The study included a diverse sample from various care services in São Luís, Brazil.
  • Participants reported high levels of polypharmacy and physical inactivity.
  • The QCQ-PC demonstrated adequate fit indices for its one-dimensional structure.

Takeaway

This study created a simple questionnaire to help doctors understand how well they are caring for diabetic patients who need palliative care.

Methodology

The study used exploratory factor analysis (EFA) to assess the structural validity of the QCQ-PC in a sample of 100 individuals with diabetes mellitus.

Potential Biases

The culture of palliative care is primarily focused on cancer patients, which may influence perceptions and practices.

Limitations

The study did not have a defined clinical approach to palliative care, which complicates determining when patients can benefit from it.

Participant Demographics

66% female, median age 64 years, 54% single, 44% overweight, 77% on polypharmacy, 70% physically inactive.

Statistical Information

P-Value

<0.01

Confidence Interval

0.000 to 0.036

Statistical Significance

p<0.01

Digital Object Identifier (DOI)

10.1186/s13098-024-01548-w

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication